Results for Diffuse Lung Disease

1 - 6 of 6

Dr. Goldfarb has special interests in the treatment of children with end-stage lung disease such as cystic fibrosis, interstitial lung disease, pulmonary late effects of oncology treatments, and other pulmonary disorders.

E-mail:

goldfarb [at] chop.edu

Sharon McGrath-Morrow, MBA, MD

Dr. McGrath-Morrow is associate chief of the Division of Pulmonary and Sleep Medicine and leader of the Post-preemie Lung Disease Clinic at Children’s Hospital of Philadelphia. Her research seeks to link early life events with adult lung health and biomarker discovery for future trials.

E-mail:

mcgrathmos [at] chop.edu

In the News: AIMBE, HERO Registry, Crazy 8, Blinatumomab, Lung Development

Published on

Mar 19, 2021

in Cornerstone Blog

In this research news roundup, new insights from the HERO registry, a targeted treatment for high-risk relapsed B-ALL, and more.

Enhancing the Effectiveness of NETs to Trap Bacteria

Published on

Jan 4, 2021

in Cornerstone Blog

Researchers work to enhance the body’s immune response to contain infection locally and prevent systemic bacterial spread.

Rare Lung Diseases Center

Transforming how rare lung diseases are diagnosed and treated in children by expanding the use of genetic and pathologic testing, enabling the clinical team to provide a more accurate diagnosis and a personalized, specific care plan for each child.

Division of Pulmonary and Sleep Medicine

Advancing pulmonary research that reflects the child-adult continuum and the trajectory of respiratory diseases and conditions.